Cardiovascular events in chronic dialysis patients: emphasizing the importance of vascular disease prevention.
Cardiovascular disease is the leading cause of death in both chronic kidney disease and peritoneal dialysis/hemodialysis patients. Vascular disease prevention in these patients is therefore important to reduce the incidence of cardiovascular events and the high morbidity and mortality. This Editorial discusses the traditional, (1) smoking, (2) dyslipidemia, (3) body mass index, (4) glycemic control and (5) blood pressure, and non-traditional, (1) anemia, (2) vitamin D/hyperparathyroidism, (3) calcium/phosphorus metabolism and (4) magnesium, risk factors in renal patients. Current evidence does not support routine statin use and antiplatelet medication to dialysis patients. Patient compliance and adherence to proposed measures could be essential to reduce cardiovascular events and mortality rates in this high-risk population.
Paraskevas
Kosmas I
KI
Department of Vascular Surgery, Red Cross Hospital, 24, Al. Papagou Street, Athens, Greece. paraskevask@hotmail.com
Kotsikoris
Ioannis
I
Koupidis
Sotirios A
SA
Tzovaras
Alexandros A
AA
Mikhailidis
Dimitri P
DP
D002318:Cardiovascular Diseases / Q000209:etiology / Q000378:metabolism / Q000517:prevention & control*; D048909:Diabetes Complications; D050171:Dyslipidemias / Q000150:complications; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D008659:Metabolic Diseases / Q000150:complications; D006435:Renal Dialysis; D012307:Risk Factors
D006454:Hemoglobins